- Home
- FHTX vs NCZ Comparison
FHTX vs NCZ Comparison
Compare FHTX & NCZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FHTX | NCZ |
|---|---|---|
| Founded | 2015 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 323.4M | 294.6M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | FHTX | NCZ |
|---|---|---|
| Price | $4.34 | $15.67 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $11.50 | N/A |
| AVG Volume (30 Days) | ★ 133.8K | 83.6K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.16% |
| EPS Growth | ★ 25.32 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $30,909,000.00 | N/A |
| Revenue This Year | $8.89 | N/A |
| Revenue Next Year | $20.13 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 36.75 | N/A |
| 52 Week Low | $3.27 | $12.15 |
| 52 Week High | $6.95 | $15.90 |
Technical Indicators
Market Signals| Indicator | FHTX | NCZ |
|---|---|---|
| Relative Strength Index (RSI) | 47.09 | 62.56 |
| Support Level | $3.62 | $13.59 |
| Resistance Level | $5.82 | $15.90 |
| Average True Range (ATR) | 0.29 | 0.29 |
| MACD | 0.04 | -0.02 |
| Stochastic Oscillator | 65.14 | 83.96 |
Price Performance
Historical ComparisonAbout FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.
About NCZ Virtus Convertible & Income Fund II of Beneficial Interest
Virtus Convertible & Income Fund II is a diversified, closed-end management investment company. The investment objective of the company is to provide total return through a combination of current income, current gains and long-term capital appreciation. Its portfolio of investments includes different sector investments such as in healthcare services, media, oil, gas, and consumable fuels and others.